Update on ENESTop: TFR in CML after discontinuing nilotinib

The ENESTop trial (NCT01698905) investigated treatment-free remission (TFR) in patients with chronic myeloid leukemia (CML) after discontinuing nilotinib, following the acheivement of a deep molecular... Author: VJHemOnc Added: 09/21/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts